Rocuronium Bromide Injection 50 mg/5 mL Vial
This is a sterile injectable solution of rocuronium bromide, a non-depolarizing neuromuscular blocking agent used to facilitate tracheal intubation and provide skeletal muscle relaxation during surgery or mechanical ventilation. It falls under HTS 3004.90.92.47 as a medicament containing rocuronium or its salts, put up in measured doses for therapeutic use primarily affecting the central nervous system via peripheral neuromuscular blockade.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If not put up in measured doses for retail sale
Bulk unmixed or mixed medicaments not in patient-ready forms classify under Chapter 30 headings for pharmaceutical substances rather than finished dosage forms.
If primarily affecting the peripheral nervous system without central action
Medicaments targeting peripheral systems without CNS primary effect fall under other CNS subcategories, but rocuronium's neuromuscular specificity might shift classification.
If imported as a chemical intermediate without therapeutic labeling
Pure rocuronium salts lacking retail packaging or dosage instructions may classify as organic compounds prepared for pharmaceutical use, not finished medicaments.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Obtain FDA approval and ensure product meets cGMP standards for sterile injectables; include Certificate of Analysis (CoA) verifying rocuronium bromide content
• Provide detailed batch testing documentation for potency, sterility, and endotoxin levels to avoid CBP holds at entry
• Label clearly with NDC code, lot number, and expiration date; beware of misclassification as general anesthetics under different subheadings
Related Products under HTS 3004.90.92.47
Rocuronium Bromide 100 mg/10 mL Single-Dose Vial
A pre-filled single-dose vial containing 100 mg of rocuronium bromide in 10 mL solution, designed for rapid sequence induction in anesthesia protocols. Classified under HTS 3004.90.92.47 due to its specific rocuronium salt content and measured dosing for therapeutic neuromuscular blockade.
Rocuronium 50 mg Multi-Dose Vial for Anesthesia
Multi-dose vial of rocuronium bromide 50 mg per mL, used in operating rooms for maintenance of muscle relaxation during prolonged procedures. It qualifies for HTS 3004.90.92.47 as a mixed product in measured doses containing rocuronium salts for CNS-affecting therapeutic use.
Rocuronium Bromide Pre-Filled Syringe 30 mg/3 mL
Ready-to-use pre-filled syringe with 30 mg rocuronium bromide for emergency airway management. Classified in HTS 3004.90.92.47 for retail-sale measured doses of this specific CNS therapeutic agent.
Pediatric Rocuronium 10 mg/1 mL Dose Vial
Low-volume pediatric formulation of rocuronium bromide 10 mg/mL for neonatal and infant anesthesia dosing precision. Falls under HTS 3004.90.92.47 as measured-dose rocuronium salt for therapeutic neuromuscular control.
Esmeron Rocuronium Bromide 10 mg/mL Infusion Bottle
Brand-name Esmeron rocuronium bromide solution at 10 mg/mL in a 5 mL infusion bottle for continuous IV administration in ICU settings. Under HTS 3004.90.92.47 for its rocuronium salt content in prophylactic/therapeutic measured doses affecting neuromuscular function.
Generic Rocuronium Bromide 200 mg/20 mL Vial
High-dose generic rocuronium bromide vial (200 mg in 20 mL) for bariatric or prolonged surgical cases requiring deeper paralysis. HTS 3004.90.92.47 applies as a CNS-affecting medicament in measured doses with rocuronium salts.